Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
280
days
Development of CRISPR_SCD001, an autologous hematopoietic stem cell gene therapy for sickle cell disease
Authors
Mark DeWitt; Beatriz Campo-Fernandez; Sohini Roy; Alissa L.W. Kleinhenz; Alejandra Davila; Mallory Lennon; Jonnathan T. Vu; Netravathi Krishnappa; Suzanne Said; Chin-hong Tseng; So Hyun Park; Gang Bao; Wendy Magis; David I.K. Martin; Dario Boffelli; Stacia K. Wyman; Donald B. Kohn; Mark C. Walters; Zulema RomeroShow moreShow less
Affiliations
Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA; Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA 94720, USA; Department of Medicine, School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Bioengineering, Rice University, Houston, TX 77005, USA; Children’s Hospital Oakland Research Institute and UCSF Benioff Children’s Hospital, Oakland, Oakland, CA 94609, USA; Cedars-Sinai Medical Center, Department of Pediatrics, Los Angeles, CA 90048, USA; Department of Pediatrics, University of California, San Francisco, San Francisco, CA and UCSF Benioff Children’s Hospital, Oakland, Oakland, CA 94609, USAShow moreShow less
310
days
Unlocking extracellular vesicle-mediated efficient DNA delivery for long-lasting transgene expression
Authors
Melissa Tan; Yumi Kawamura; Carol Wang; Ryan Schneider; George Richards; Odom Seng; William Eagen; Dean Lee; Evonne Ip; Desmond Wai Loon Chin; Wei Zhong Leong; Walter Goh; Harwin Sidik; Trinh T.T. Tran; Ozan Alkan; Qin Yu; Ronne Yeo; Don Haut; Tenzin Gocha; Minh T.N. Le; Waqas Muhammad UsmanShow moreShow less
Affiliations
Carmine Therapeutics Pte. Ltd., Singapore, Singapore; Institute for Digital Medicine and Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; College of Health Sciences, Research Institute of Immunology, Vin University, Hanoi, Vietnam; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Institute of Molecular and Cell Biology, A∗STAR, Singapore, SingaporeShow moreShow less
187
days
A helicase-fused Cas9 improves large-size fragment knockin
Authors
Duowei Zhao; Xiangjie Zhao; Yuhang Gao; Sujie Yang; Xiaochen Guo; Caiyan Zhang; Chuanpei Li; Chengda Zhang; Huan Tian; Qianqian Xu; Zhi Yin; Zhonghua Liu; Jun SongShow moreShow less
Affiliations
Key Laboratory of Animal Cellular and Genetics Engineering of Heilongjiang Province, College of Life Science, Northeast Agricultural University, Harbin 150030, ChinaShow moreShow less
211
days
Repurposing triamterene as chloride intracellular channel 1 inhibitor via ligand-based approach for glioblastoma
Authors
Federica Barbieri; Francesca Cianci; Beatrice Federica Tremonti; Irene Dellacasagrande; Alessandro Corsaro; Guido Rey; Stefano Thellung; Noemi Barsotti; Valeria Marini; Manuela Stella; Giammarco Baiardi; Francesca Mattioli; Adriana Bajetto; Alessandra Pattarozzi; Pietro Amodeo; Michele Mazzanti; Rosa Maria Vitale; Tullio FlorioShow moreShow less
Affiliations
Section of Pharmacology, Department of Internal Medicine, University of Genova, Viale Benedetto XV 2, 16132 Genova, Italy; AOM-IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genova, Italy; Department of Biosciences, University of Milano, Via Celoria 26, 20133 Milano, Italy; Department of Biology, Unit of Cell and Developmental Biology, University of Pisa, 56127 Pisa, Italy; IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy; Institute of Biomolecular Chemistry, National Research Council (ICB-CNR), Via Campi Flegrei 34, 80078 Pozzuoli, (NA), ItalyShow moreShow less
301
days
A singular base-editing platform for polyfunctional multiplex engineering of immune cells
Authors
Joseph G. Skeate; Nicholas J. Slipek; Walker S. Lahr; Shambojit Roy; Bryce J. Wick; Bibekananda Kar; Jae-Woong Chang; Erin M. Stelljes; Alexandria K. Gilkey; Prateek P. Thenge; Miechaleen D. Diers; Joshua B. Krueger; Ethan M. Niemeyer; Cara-lin Lonetree; Mitchell G. Kluesner; Jason B. Bell; Kendell Clement; Paolo P. Provenzano; Branden S. Moriarity; Beau R. WebberShow moreShow less
Affiliations
Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Center for Genome Engineering, University of Minnesota, Minneapolis, MN, USA; Department of Biomedical Engineering, University of Minnesota, Minneapolis, MN, USA; UMN Center for Multiparametric Imaging of Tumor Immune Microenvironments (C-MITIE), University of Minnesota, Minneapolis, MN, USA; Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN, USA; Center for Immunology, University of Minnesota, Minneapolis, MN, USA; Molecular and Cellular Biology Graduate Program, Fred Hutchinson Cancer Center, Seattle, WA, USA; Medical Scientist Training Program, University of Washington, Seattle, WA, USA; Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, USA; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA; Stem Cell Institute, University of Minnesota, Minneapolis, MN, USAShow moreShow less
114
days
Injectable bioinstructive microfoam for rapid bedside/in vivo programming of CAR-T cells
Authors
Sirkka B. Stephan; Carrie L. Cummings; Katelyn Fitzgerald; Hoku West-Foyle; Eric J. Cavanaugh; Inci Cevher Zeytin; Stefan Radtke; Hans-Peter Kiem; Andras A. Heczey; Matthias T. StephanShow moreShow less
Affiliations
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Cellular Imaging Shared Resource, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Stem Cell and Gene Therapy Program, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA 98195, USA; Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children’s Research Institute, Seattle Children’s Hospital, Seattle, WA 98101, USA; Department of Pediatrics, University of Washington, Seattle, WA 98105, USA; Department of Bioengineering and Molecular Engineering & Sciences Institute, University of Washington, Seattle, WA 98109, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA 98195, USAShow moreShow less
FAQ
How long does MOLECULAR THERAPY take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for MOLECULAR THERAPY. The fastest paper went from submission to acceptance in 114 days (Injectable bioinstructive microfoam for rapid bedside/in vivo programming of CAR-T cells, received 2026-03-23, accepted 2026-07-15); the slowest took 310 days. The average is 211.7 days and the median is 196 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
